Stephen O. Evans

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

Fiona L. Dignan, Dorothy M. Gujral, Mark Ethell et al. · Bone Marrow Transplantation · 2007 · 81 citations

Transplantation, Marrow Transplantation, Prophylactic Defibrotide +9

An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality

Fiona L. Dignan, Stephen O. Evans, Mark Ethell et al. · Bone Marrow Transplantation · 2009 · 51 citations

Antifungal Agent, Transplantation, Low Mortality +4

High readmission rates are associated with a significant economic burden and poor outcome in patients with grade <scp>III</scp>/<scp>IV</scp> acute <scp>G</scp>v<scp>HD</scp>

Fiona L. Dignan, Mike Potter, Mark Ethell et al. · Clinical Transplantation · 2012 · 34 citations

Dose-related endocrine effects of pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients

Mitch Dowsett, David Cunningham, Stephen O. Evans et al. · Maturitas · 1989 · 31 citations

Dose-related Endocrine Effects, Breast Oncology, Oncology +8

Identification of multiple human calcitonin receptor isoforms: heterologous expression and pharmacological characterization

M Egerton, M. Needham, Stephen O. Evans et al. · Journal of Molecular Endocrinology · 1995 · 27 citations

Pharmacological Characterization, T47d Mrna, Cancer Biology +16